Showing results (211-220 of 309) with videos related to

Sort By:
Pageof 31
International Journal of Clinical Monitoring and Computing|October 1, 1993
Heart rate variability and severe brain damage: preliminary dataL G Lacquaniti, M Irone, S Barbacini, et al.
Parasite Immunology|October 1, 2011
Immune-related genes expression profile in orange-spotted grouper during exposure to Cryptocaryon irritansY W Li, X M Dan, T W Zhang, et al.
EDTNA/ERCA Journal (English Ed.)|October 10, 2002
Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trialC Ronco, R Belomo, P Homel, et al.
Annals of the Rheumatic Diseases|December 1, 1989
Fluctuations of anticardiolipin antibody levels in patients with systemic lupus erythematosus: a prospective studyH J Out, P G de Groot, P Hasselaar, et al.
Brain : a Journal of Neurology|April 17, 2012
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injurySteven Casha, David Zygun, M Dan McGowan, et al.
FEBS Letters|August 7, 1995
Selective inhibition of gastrulation in the starfish embryo by albuside B, an inosine analogueT Shimizu, K Hamada, H Isomura, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 20, 2002
Increasing incidence of gonorrhea in Israel associated with countrywide dissemination of a ciprofloxacin-resistant strainP Yagupsky, A Schahar, N Peled, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogensR Raz, B Chazan, Y Kennes, et al.
The British Journal of Dermatology|November 4, 2014
Cutaneous leishmaniasis responds to daylight-activated photodynamic therapy: proof of concept for a novel self-administered therapeutic modalityC D Enk, A Nasereddin, R Alper, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1995
Phase I trial of sequential cyclophosphamide, cyclosporin A, and interferon-alpha in patients with cancer: attempt to induce autologous graft-versus-host reaction to elicit an antitumor responseB G Redman, T H Chou, M Zalupski, et al.
Pageof 31